AHA Coding Clinic® for HCPCS - 2016 Quarter 1; For Your Information
Reporting for the Cologuard test
The Cologuard test is the first stool-based colorectal screening test able to detect the presence of red blood cells and DNA mutations that may indicate the presence of certain abnormal growths which may be cancerous, such as, colon cancer or precursors to cancer. As of January 1, 2016, the Cologuard test should be reported with CPT code 81528 , Oncology (colorectal) screening , quantitative real-time target and signal amplification of 10 DNA markers ( KRAS mutations, promoter methylation of NDRG4 and BMP3 ) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result. ...
Subscribe or sign in to view the full article.
Article Overview
This short coding article focuses on reporting guidance for the Cologuard stool-based colorectal screening test. It is aimed at coding, billing, and compliance professionals who need a quick reference for the relevant CPT reporting approach and the effective date mentioned in the article.
Why This Topic Matters
Correct reporting of this colorectal screening service affects claims accuracy, consistent coding, and alignment with current guidance.
What You Will Learn
- The general purpose of the Cologuard colorectal screening test
- Which coding area the article addresses
- The effective date associated with the reporting guidance
- How the article frames the test in relation to colorectal screening reporting
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Revenue cycle teams
- Clinical documentation specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com